PharmaShots | Incisive News in 3 Shots

Subscribe Now

chronic renal failure

Lotus Signs an Exclusive Commercialization Agreement with CKD for Biosimilar Darbepoetin Alfa

Lotus Signs an Exclusive Commercialization Agreement with CKD for Biosimilar Darbepoetin Alfa

September 18, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us